PCSK9 and coronary artery disorder: The following paradoxical results have been obtained:23 (1) CAC progression is an independent predictor of CAD events; (2) statins and/or PCSK9 inhibitors promote plaque regression; and (3) statins promote CAC progression (Fig. 3).